IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Wockhardt Buys French Pharma Company for $265 Million

1:20 PM MDT | August 9, 2007 | Deepti Ramesh

Wockhardt Ltd. (Mumbai), a pharmaceutical and biotechnology company, has acquired Negma Laboratories (Paris), the fourth-largest pharmaceutical group in France, for $265 million. The acquisition, Wockhardt’s fifth in Europe, means that European sales will account for more than 60% of the company’s total. Negma, with annual sales of $150 million, has a portfolio of 172 patents, and a range of pharma products in various stages of development. “Negma is a unique acquisition for Wockhardt,” says Habil Khorakiwala, chairman of Wockhardt...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa